share_log

Verrica Pharmaceuticals | 8-K: Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

SEC ·  Nov 4 16:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more